Monopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Update

Monopar Therapeutics Inc. (NASDAQ:MNPR – Get Free Report) was the target of a large decline in short interest in November. As of November 30th, there was short interest totalling 22,000 shares, a decline of 18.2% from the November 15th total of 26,900 shares. Based on an average trading volume of 1,240,000 shares, the short-interest ratio […]

Leave a Reply

Your email address will not be published.

Previous post Synaptogenix, Inc. (NASDAQ:SNPX) Short Interest Up 30.9% in November
Next post UN envoy calls for increased aid for Syria in Damascus visit